Value through Innovation27 July 2016

Clinical Study Results

  • ALESION ® - Dermatitis, Atopic
    Clinical Study Number 262.259
    Study Indication Dermatitis, Atopic
    Product ALESION ®
    Generic Name Epinastine
    Lab Code
    Clinical Phase III
    Study Title

    Phase III Double-Blind Comparative Study of WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis Patients

    Study Document Trial synopsis 262.259 english
  • ALESION ® - Dermatitis, Atopic
    Clinical Study Number 262.260
    Study Indication Dermatitis, Atopic
    Product ALESION ®
    Generic Name Epinastine
    Lab Code
    Clinical Phase III
    Study Title

    Phase III Open-labeled Study of WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis Patients

    Study Document Trial synopsis 262.260 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.